Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021
Clara Mazagatos(Instituto de Salud Carlos III), Aurora Limia(Universidad Rey Juan Carlos), Susana Monge(Instituto de Salud Carlos III), Amparo Larrauri(Instituto de Salud Carlos III), Pilar Gallego(Hospital Universitario Virgen de la Arrixaca), Lorena Vega(Instituto de Salud Carlos III), María José Sierra(Ministerio de Salud Pública), Elisa Martín‐Merino(Pharmaceuticals and Medical Devices Agency), Carmen Olmedo
Cited by 84
Related Papers
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303
Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021
|Eurosurveillance|2021|281